Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Gains from Investment Securities (2016 - 2025)

Rocket Pharmaceuticals (RCKT) has disclosed Gains from Investment Securities for 10 consecutive years, with $5.6 million as the latest value for Q3 2025.

  • Quarterly Gains from Investment Securities rose 2777.43% to $5.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, up 191.21% year-over-year, with the annual reading at $2.7 million for FY2025, 586.92% up from the prior year.
  • Gains from Investment Securities hit $5.6 million in Q3 2025 for Rocket Pharmaceuticals, down from $16.4 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $16.4 million in Q2 2025 to a low of -$2.4 million in Q4 2023.
  • Historically, Gains from Investment Securities has averaged $4.1 million across 5 years, with a median of $467172.0 in 2022.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 357807.17% in 2022 and later plummeted 4854.0% in 2023.
  • Year by year, Gains from Investment Securities stood at $5.2 million in 2021, then tumbled by 99.04% to $50000.0 in 2022, then tumbled by 4854.0% to -$2.4 million in 2023, then skyrocketed by 99.96% to -$1000.0 in 2024, then skyrocketed by 562335.2% to $5.6 million in 2025.
  • Business Quant data shows Gains from Investment Securities for RCKT at $5.6 million in Q3 2025, $16.4 million in Q2 2025, and -$1000.0 in Q4 2024.